Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Alitretinoin in the Treatment of Chronic Hand Eczema [Phase 3]
Phase 3 clinical trial of alitretinoin for chronic hand eczema has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase II study in adults with moderate to severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects [Phase 3]
A Phase 3 trial evaluating IDP-124 Lotion for moderate-to-severe atopic dermatitis in adults and children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301) [Phase 3]
Phase 3 trial update on IDP-124 Lotion for moderate to severe atopic dermatitis in adults and children; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating MSTT1041A for moderate to severe atopic dermatitis has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 trial update on safety and efficacy of CD5024 0.3% Cream in adults with atopic dermatitis; results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response [Phase 4]
Phase 4 trial exploring optimization of cyclosporin in atopic dermatitis using multiomic predictive models to predict treatment response.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD) [Phase 2]
Phase 2 PK and safety study of nemolizumab in adolescents with atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function [Phase 2]
Phase 2 trial evaluating tralokinumab for atopic dermatitis and its effects on skin barrier function has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for jaktinib in moderate to severe atopic dermatitis completed.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo [Phase 2]
Phase 2 trial evaluating a new phototherapy regimen plus oral vitamin D versus placebo for long-term control in atopic dermatitis, completed…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis [Phase 3]
Phase 3 study evaluating long-term maintenance treatment with once-daily Crisaborole 2% ointment in pediatric and adult patients with mild-t…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating safety of upadacitinib in combination with topical corticosteroids for moderate to severe atopic dermatitis in adol…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of bermekimab in moderate to severe atopic dermatitis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial assessing safety and efficacy of lebrikizumab in adolescents with moderate-to-severe atopic dermatitis has completed and resul…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial update on ARQ-151 Cream showing safety and efficacy in adolescents and adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Metal Panel Allergen Patch Test Study [Phase 3]
A Phase 3 clinical trial update for a metal panel allergen patch test study in atopic dermatitis (eczema) is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis [Phase 2]
Phase 2 trial comparing Lindioil ointment to Protopic ointment in atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment [Phase 4]
Phase 4 trial evaluating functionally relevant signature genes to assess outcomes of dupilumab in atopic dermatitis/eczema.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 trial update assessing PF-04965842 monotherapy for moderate-to-severe atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating KY1005 in patients with moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: The Study of CM326 in Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for CM326 in moderate-to-severe atopic dermatitis is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis [Phase 4]
Phase 4 trial investigating Staphylococcus aureus and skin microbiome dynamics during flare and resolution in atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for evaluation of 611 in Chinese adults with moderate-to-severe atopic dermatitis (Phase 1/2) completed.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating a mixed Chinese herbal formula for atopic dermatitis is ongoing with unknown status.